Amylyx Pharmaceuticals Inc (AMLX) — Cash Flow Quality Index
Amylyx Pharmaceuticals Inc (AMLX) has a Cash Flow Quality Index of 2.86x as of December 2023. Operating cash flow of $13.55 Million exceeds net income of $4.73 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Amylyx Pharmaceuticals Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Amylyx Pharmaceuticals Inc Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Amylyx Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AMLX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year earnings quality comparison for Amylyx Pharmaceuticals Inc. For live market cap and the full company financial profile, see AMLX stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.24x | $11.92 Million | $49.27 Million | — |